Compile Data Set for Download or QSAR
Report error Found 122 Enz. Inhib. hit(s) with Target = 'Tyrosine-protein kinase BTK [328-659]'
TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514921BDBM514921(US11098041, Example 151)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514922BDBM514922(US11098041, Example 152)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514923BDBM514923(US11098041, Example 153)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514780BDBM514780(US11098041, Example 2)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514783BDBM514783(US11098041, Example 5)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514784BDBM514784(US11098041, Example 6)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514788BDBM514788(US11098041, Example 10)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514789BDBM514789(US11098041, Example 11)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514898BDBM514898(US11098041, Example 125)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514899BDBM514899(US11098041, Example 126)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514900BDBM514900(US11098041, Example 127)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514901BDBM514901(US11098041, Example 129)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514902BDBM514902(US11098041, Example 130)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514904BDBM514904(US11098041, Example 132)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514908BDBM514908(US11098041, Example 136)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514911BDBM514911(US11098041, Example 139)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514912BDBM514912(US11098041, Example 140)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514913BDBM514913(US11098041, Example 142 | US11098041, Example 141)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514915BDBM514915(US11098041, Example 144)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514916BDBM514916(US11098041, Example 145)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514918BDBM514918(US11098041, Example 148)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514919BDBM514919(US11098041, Example 149)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514920BDBM514920(US11098041, Example 150)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514811BDBM514811(US11098041, Example 34)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514812BDBM514812(US11098041, Example 35)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514813BDBM514813(US11098041, Example 37)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514815BDBM514815(US11098041, Example 39)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514816BDBM514816(US11098041, Example 40)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514817BDBM514817(US11098041, Example 41)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514818BDBM514818(US11098041, Example 42)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514820BDBM514820(US11098041, Example 44)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514821BDBM514821(US11098041, Example 45)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514791BDBM514791(US11098041, Example 13)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514792BDBM514792(US11098041, Example 14)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514793BDBM514793(US11098041, Example 15)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514794BDBM514794(US11098041, Example 16)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514795BDBM514795(US11098041, Example 17)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514796BDBM514796(US11098041, Example 18)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514797BDBM514797(US11098041, Example 19)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514798BDBM514798(US11098041, Example 20)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514799BDBM514799(US11098041, Example 21)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514804BDBM514804(US11098041, Example 26)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514805BDBM514805(US11098041, Example 27)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514842BDBM514842(US11098041, Example 66)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514843BDBM514843(US11098041, Example 67)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514846BDBM514846(US11098041, Example 70)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514847BDBM514847(US11098041, Example 71)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514850BDBM514850(US11098041, Example 74)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514851BDBM514851(US11098041, Example 75)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 514852BDBM514852(US11098041, Example 76)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

Displayed 1 to 50 (of 122 total ) | Next | Last >>
Jump to: